Share Price and Basic Stock Data
Last Updated: December 29, 2025, 2:39 pm
| PEG Ratio | -1.80 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Deccan Cements Ltd operates in the cement industry, with a current share price of ₹763 and a market capitalization of ₹1,068 Cr. The company’s revenue trends indicate fluctuations in sales over the past quarters. For instance, sales stood at ₹194 Cr in June 2022, dipped to ₹167 Cr by September 2023, and rebounded to ₹217 Cr in December 2023. However, sales projections for the subsequent quarters show a decline, with ₹120 Cr recorded in September 2024, followed by ₹115 Cr in December 2024. The annual sales figures tell a similar story, with ₹782 Cr reported for the fiscal year ending March 2023, slightly improving to ₹799 Cr for March 2024, but anticipated to drop significantly to ₹527 Cr in March 2025. This inconsistent revenue performance reflects the challenges faced in the cement sector, including fluctuating demand and increased competition.
Profitability and Efficiency Metrics
Deccan Cements’ profitability metrics reveal a concerning trend. The operating profit margin (OPM) fluctuated, reaching a peak of 19% but declining to 11% for the fiscal year ending March 2025. The net profit for the latest quarter was reported at ₹15 Cr, with an earnings per share (EPS) of ₹10.96 for June 2025. The company also recorded a return on equity (ROE) of 0.75% and a return on capital employed (ROCE) of 1.53%, both of which are significantly lower than industry norms. The interest coverage ratio (ICR) is relatively healthy at 4.04, indicating that the company can comfortably cover its interest obligations. However, the cash conversion cycle (CCC) stood at 386 days, suggesting inefficiencies in managing working capital, which may impact liquidity and operational efficiency.
Balance Sheet Strength and Financial Ratios
Deccan Cements’ balance sheet reflects a cautious financial position. The company reported total borrowings of ₹760 Cr against reserves of ₹739 Cr, highlighting a high dependency on debt financing. The debt-to-equity ratio stood at 0.98, indicating a balanced approach to leverage but also a potential risk if market conditions deteriorate. The current ratio is a modest 1.17, suggesting adequate short-term liquidity. The price-to-book value (P/BV) ratio is recorded at 1.52x, which may be seen as relatively high compared to peers in the sector, indicating that the stock is priced at a premium relative to its book value. Additionally, the dividend payout ratio is reported at 55.89%, signifying a commitment to returning value to shareholders, albeit at the cost of retained earnings for growth.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Deccan Cements reveals a stable structure, with promoters holding 56.24% of the equity. This level of promoter ownership typically indicates strong management control and commitment. Foreign institutional investors (FIIs) have increased their stake to 9.93%, reflecting a moderate level of foreign interest, while domestic institutional investors (DIIs) maintain a lower stake at 0.90%. The public shareholding stands at 32.92%, with a gradual decline in the number of shareholders from 17,605 in December 2022 to 11,952 by September 2025. This decline may raise concerns regarding investor confidence and market sentiment towards the company. The stability in promoter holdings, juxtaposed with the reduction in public shareholders, suggests a need for the company to bolster its outreach and engagement with retail investors.
Outlook, Risks, and Final Insight
The outlook for Deccan Cements appears mixed, characterized by both opportunities and risks. The company has the potential to enhance its profitability through operational efficiencies and cost management, particularly in managing its high cash conversion cycle. However, the significant reliance on debt financing poses risks, especially in a volatile market environment. The fluctuating revenue trends and declining net profits indicate that the company must adapt to changing market conditions and consumer demands. Should Deccan Cements manage to optimize its operations and stabilize its sales figures, there could be a positive turnaround. Conversely, continued declines in revenue and profitability could lead to increased financial strain. The company’s ability to navigate these challenges will be critical in determining its future performance and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 21.6/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,47,665 Cr. | 11,799 | 13,102/10,048 | 47.4 | 2,444 | 0.66 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 24,912 Cr. | 1,057 | 1,209/788 | 129 | 322 | 0.19 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 13,915 Cr. | 448 | 451/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 9,051 Cr. | 225 | 309/196 | 29.9 | 74.4 | 0.44 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 37,858.69 Cr | 1,908.52 | 37.61 | 573.47 | 0.54% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 180 | 211 | 196 | 192 | 167 | 217 | 223 | 172 | 120 | 115 | 119 | 151 |
| Expenses | 159 | 164 | 186 | 175 | 167 | 154 | 188 | 197 | 161 | 118 | 107 | 106 | 123 |
| Operating Profit | 35 | 17 | 25 | 21 | 25 | 14 | 29 | 26 | 11 | 2 | 9 | 13 | 28 |
| OPM % | 18% | 9% | 12% | 10% | 13% | 8% | 13% | 12% | 7% | 2% | 8% | 11% | 19% |
| Other Income | 3 | 2 | 2 | 3 | 3 | 4 | 4 | -11 | 3 | 3 | 3 | 7 | 3 |
| Interest | 3 | 3 | 3 | 4 | 2 | 3 | 4 | 3 | 3 | 3 | 4 | 3 | 3 |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Profit before tax | 28 | 9 | 17 | 13 | 19 | 8 | 22 | 5 | 4 | -5 | 1 | 10 | 20 |
| Tax % | 25% | 27% | 26% | 26% | 26% | 38% | 30% | 36% | 35% | -26% | 45% | 24% | 25% |
| Net Profit | 21 | 7 | 12 | 10 | 14 | 5 | 15 | 3 | 3 | -4 | 1 | 8 | 15 |
| EPS in Rs | 14.76 | 4.69 | 8.68 | 7.07 | 10.09 | 3.38 | 10.99 | 2.15 | 2.01 | -2.88 | 0.58 | 5.68 | 10.96 |
Last Updated: August 20, 2025, 11:45 am
Below is a detailed analysis of the quarterly data for Deccan Cements Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 119.00 Cr. (Mar 2025) to 151.00 Cr., marking an increase of 32.00 Cr..
- For Expenses, as of Jun 2025, the value is 123.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 106.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 17.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 15.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Mar 2025) to 19.00%, marking an increase of 8.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 10.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 10.96. The value appears strong and on an upward trend. It has increased from 5.68 (Mar 2025) to 10.96, marking an increase of 5.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 441 | 407 | 625 | 496 | 570 | 651 | 555 | 758 | 792 | 782 | 799 | 527 | 525 |
| Expenses | 383 | 343 | 511 | 396 | 484 | 556 | 477 | 582 | 630 | 684 | 704 | 492 | 455 |
| Operating Profit | 57 | 64 | 115 | 100 | 86 | 95 | 79 | 176 | 162 | 97 | 96 | 35 | 70 |
| OPM % | 13% | 16% | 18% | 20% | 15% | 15% | 14% | 23% | 20% | 12% | 12% | 7% | 13% |
| Other Income | 2 | 3 | 1 | 2 | 3 | 10 | -0 | 10 | -8 | 9 | -2 | 16 | 15 |
| Interest | 27 | 27 | 15 | 7 | 6 | 8 | 7 | 8 | 10 | 13 | 13 | 13 | 13 |
| Depreciation | 24 | 19 | 20 | 22 | 23 | 22 | 21 | 23 | 26 | 27 | 28 | 28 | 27 |
| Profit before tax | 7 | 21 | 81 | 74 | 61 | 75 | 51 | 155 | 117 | 67 | 53 | 11 | 45 |
| Tax % | 33% | 6% | 43% | 36% | 37% | 39% | -12% | 26% | 25% | 26% | 30% | 30% | |
| Net Profit | 5 | 20 | 46 | 47 | 39 | 46 | 57 | 115 | 88 | 49 | 37 | 8 | 33 |
| EPS in Rs | 3.59 | 14.20 | 32.54 | 33.48 | 27.52 | 32.88 | 40.44 | 82.19 | 62.52 | 35.20 | 26.60 | 5.38 | 23.70 |
| Dividend Payout % | 17% | 9% | 8% | 9% | 11% | 11% | 10% | 6% | 8% | 11% | 11% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 300.00% | 130.00% | 2.17% | -17.02% | 17.95% | 23.91% | 101.75% | -23.48% | -44.32% | -24.49% | -78.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | -170.00% | -127.83% | -19.20% | 34.97% | 5.96% | 77.84% | -125.23% | -20.84% | 19.83% | -53.89% |
Deccan Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -1% |
| 3 Years: | -13% |
| TTM: | -35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -35% |
| 3 Years: | -58% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 28% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 223 | 238 | 279 | 325 | 358 | 399 | 443 | 558 | 639 | 680 | 712 | 715 | 739 |
| Borrowings | 239 | 191 | 79 | 70 | 33 | 54 | 106 | 104 | 166 | 265 | 520 | 714 | 760 |
| Other Liabilities | 119 | 114 | 127 | 132 | 161 | 161 | 155 | 193 | 173 | 202 | 207 | 189 | 194 |
| Total Liabilities | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 | 1,700 |
| Fixed Assets | 373 | 356 | 342 | 377 | 363 | 354 | 378 | 446 | 453 | 440 | 423 | 402 | 389 |
| CWIP | 35 | 33 | 34 | 0 | 4 | 9 | 62 | 12 | 21 | 241 | 514 | 805 | 895 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 180 | 161 | 116 | 157 | 192 | 258 | 271 | 404 | 511 | 474 | 509 | 417 | 416 |
| Total Assets | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 | 1,700 |
Below is a detailed analysis of the balance sheet data for Deccan Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Reserves, as of Sep 2025, the value is 739.00 Cr.. The value appears strong and on an upward trend. It has increased from 715.00 Cr. (Mar 2025) to 739.00 Cr., marking an increase of 24.00 Cr..
- For Borrowings, as of Sep 2025, the value is 760.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 714.00 Cr. (Mar 2025) to 760.00 Cr., marking an increase of 46.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 194.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 189.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,700.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 389.00 Cr.. The value appears to be declining and may need further review. It has decreased from 402.00 Cr. (Mar 2025) to 389.00 Cr., marking a decrease of 13.00 Cr..
- For CWIP, as of Sep 2025, the value is 895.00 Cr.. The value appears strong and on an upward trend. It has increased from 805.00 Cr. (Mar 2025) to 895.00 Cr., marking an increase of 90.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 416.00 Cr.. The value appears to be declining and may need further review. It has decreased from 417.00 Cr. (Mar 2025) to 416.00 Cr., marking a decrease of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,700.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
However, the Borrowings (760.00 Cr.) are higher than the Reserves (739.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -182.00 | -127.00 | 36.00 | 30.00 | 53.00 | 41.00 | -27.00 | 72.00 | -4.00 | -168.00 | -424.00 | -679.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 27 | 5 | 8 | 9 | 9 | 31 | 12 | 11 | 13 | 25 | 40 |
| Inventory Days | 935 | 712 | 397 | 464 | 364 | 374 | 493 | 341 | 349 | 601 | 408 | 541 |
| Days Payable | 164 | 152 | 150 | 25 | 16 | 27 | 169 | 218 | 132 | 291 | 164 | 194 |
| Cash Conversion Cycle | 793 | 587 | 251 | 446 | 357 | 356 | 355 | 135 | 227 | 323 | 268 | 386 |
| Working Capital Days | 27 | 15 | -2 | 3 | 22 | 10 | 1 | -34 | -51 | -32 | -45 | -65 |
| ROCE % | 7% | 11% | 24% | 21% | 17% | 19% | 13% | 27% | 20% | 9% | 8% | 2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 5.00 |
| Basic EPS (Rs.) | 5.37 |
| Diluted EPS (Rs.) | 5.37 |
| Cash EPS (Rs.) | 25.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 515.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 515.74 |
| Revenue From Operations / Share (Rs.) | 376.21 |
| PBDIT / Share (Rs.) | 36.81 |
| PBIT / Share (Rs.) | 16.77 |
| PBT / Share (Rs.) | 7.67 |
| Net Profit / Share (Rs.) | 5.37 |
| NP After MI And SOA / Share (Rs.) | 5.37 |
| PBDIT Margin (%) | 9.78 |
| PBIT Margin (%) | 4.45 |
| PBT Margin (%) | 2.03 |
| Net Profit Margin (%) | 1.42 |
| NP After MI And SOA Margin (%) | 1.42 |
| Return on Networth / Equity (%) | 1.04 |
| Return on Capital Employeed (%) | 1.76 |
| Return On Assets (%) | 0.46 |
| Long Term Debt / Equity (X) | 0.75 |
| Total Debt / Equity (X) | 0.98 |
| Current Ratio (X) | 1.17 |
| Quick Ratio (X) | 0.82 |
| Dividend Payout Ratio (NP) (%) | 55.89 |
| Dividend Payout Ratio (CP) (%) | 11.80 |
| Earning Retention Ratio (%) | 44.11 |
| Cash Earning Retention Ratio (%) | 88.20 |
| Interest Coverage Ratio (X) | 4.04 |
| Interest Coverage Ratio (Post Tax) (X) | 1.59 |
| Enterprise Value (Cr.) | 1670.92 |
| EV / Net Operating Revenue (X) | 3.17 |
| EV / EBITDA (X) | 32.40 |
| MarketCap / Net Operating Revenue (X) | 2.09 |
| Retention Ratios (%) | 44.10 |
| Price / BV (X) | 1.52 |
| Price / Net Operating Revenue (X) | 2.09 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Deccan Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 25.41. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 376.21. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.81. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.77. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.67. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 4.45. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.75. This value is within the healthy range. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.98. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.89. This value exceeds the healthy maximum of 50. No previous period data is available for comparison.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.80. This value is below the healthy minimum of 20. No previous period data is available for comparison.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.11. This value is within the healthy range. No previous period data is available for comparison.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.20. This value exceeds the healthy maximum of 70. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.04. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,670.92. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 32.40. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For Retention Ratios (%), as of Mar 25, the value is 44.10. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 1.52. This value is within the healthy range. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deccan Cements Ltd:
- Net Profit Margin: 1.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.76% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.04% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.82
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.7 (Industry average Stock P/E: 37.61)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.42%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Deccan Chambers, Hyderabad Telangana 500082 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. P Parvathi | Chairperson & Managing Director |
| Mr. S Venkateswarlu | Whole Time Director |
| Mrs. Mahpara Ali | Director |
| Mr. Paturi Srinivasa Rao | Director |
| Mr. Srivari Chandrasekhar | Director |
| Mr. Rabindra Srikantan | Director |
FAQ
What is the intrinsic value of Deccan Cements Ltd?
Deccan Cements Ltd's intrinsic value (as of 29 December 2025) is 101.46 which is 86.47% lower the current market price of 750.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,051 Cr. market cap, FY2025-2026 high/low of 1,184/575, reserves of ₹739 Cr, and liabilities of 1,700 Cr.
What is the Market Cap of Deccan Cements Ltd?
The Market Cap of Deccan Cements Ltd is 1,051 Cr..
What is the current Stock Price of Deccan Cements Ltd as on 29 December 2025?
The current stock price of Deccan Cements Ltd as on 29 December 2025 is 750.
What is the High / Low of Deccan Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deccan Cements Ltd stocks is 1,184/575.
What is the Stock P/E of Deccan Cements Ltd?
The Stock P/E of Deccan Cements Ltd is 31.7.
What is the Book Value of Deccan Cements Ltd?
The Book Value of Deccan Cements Ltd is 533.
What is the Dividend Yield of Deccan Cements Ltd?
The Dividend Yield of Deccan Cements Ltd is 0.08 %.
What is the ROCE of Deccan Cements Ltd?
The ROCE of Deccan Cements Ltd is 1.53 %.
What is the ROE of Deccan Cements Ltd?
The ROE of Deccan Cements Ltd is 0.75 %.
What is the Face Value of Deccan Cements Ltd?
The Face Value of Deccan Cements Ltd is 5.00.